Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA02 - Novel Therapies in ROS1, HER2 and EGFR
- 10:30 - 12:00
- 9/24/2018
- Location: Room 105
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA02.03 - Clinical Activity of Lorlatinib in Patients with ROS1+ Advanced Non-Small Cell Lung Cancer: Phase 2 Study Cohort EXP-6
10:50 - 11:00 | Presenter: Sai-Hong Ignatius Ou | Author(s): Alice T. Shaw, Gregory J Riely, Rita Chiari, Jessica R. Bauman, Jill S. Clancy, Holger Thurm, Gerson Peltz, Antonello Abbattista, Ben J Solomon
- Abstract
Loading...
-
+
MA04 - Novel Approaches with IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Immunooncology
-
+
MA04.03 - Immunotherapy for Non-Small Cell Lung Cancers (NSCLC) with Oncogenic Driver Mutations: New Results from the Global IMMUNOTARGET Registry
13:40 - 13:45 | Presenter: Oliver Gautschi | Author(s): Alexander Drilon, Julie Milia, Amelie Lusque, Laurent Mhanna, Bob T. Li, Joshua K Sabari, Alexis B Cortot, Benjamin Besse, Laura Mezquita, Ben J Solomon, Alesha A Thai, Sebastien Couraud, Remi Veillon, Céline Mascaux, Fabrice Barlesi, Michael Van Den Heuvel, Robert D Schouten, Heather A Wakelee, Angela Mah, Ross Camidge, Terry L. Ng, Nir Peled, Yosef Lilach, Sanjay Popat, Sai-Hong Ignatius Ou, Viola Zhu, Vamsidhar Velcheti, Alessandra Curioni Fontecedro, Dilara Akhoundova, Martin Früh, Gerard Zalcman, Valerie Gounant, Silvia Novello, Paolo Bironzo, Enriqueta Felip, Alex Martinez-Marti, Denis Moro-Sibilot, Rafael Rosell, Niki Karachaliou, Martin Schuler, Martin Wiesweg, Joachim Diebold, Julien Mazieres
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-06 - First-Line Lorlatinib Versus Crizotinib for Advanced Anaplastic Lymphoma Kinase-Positive (ALK+) Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Alice T. Shaw | Author(s): Todd M. Bauer, Toshiaki Takahashi, Christina S Baik, Yasushi Goto, Anna Polli, Marina Carpentieri, Jean-François Martini, Ben J Solomon
- Abstract
Loading...
-
+
MA16 - Novel Mechanisms for Molecular Profiling
- 13:30 - 15:00
- 9/25/2018
- Location: Room 203 BD
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA16.07 - Discussant - MA 16.04, MA 16.05, MA 16.06
14:10 - 14:25 | Presenter: Ben J Solomon
- Abstract
No abstract available for this presentation
-
+
OA12 - Novel Therapies in MET, RET and BRAF
- 15:15 - 16:45
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA12.02 - Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer
15:25 - 15:35 | Presenter: Alexander Drilon | Author(s): Jeffrey W. Clark, Jared Weiss, Sai-Hong Ignatius Ou, Ross Camidge, Ben J Solomon, Gregory A. Otterson, Liza Villaruz, Gregory J Riely, Rebecca Heist, Geoffrey I. Shapiro, Danielle A. Murphy, Sherry C. Wang, Tiziana Usari, Sherry Li, Keith D. Wilner, Paul K. Paik
- Abstract
Loading... -
+
OA12.07 - Clinical Activity of LOXO-292, a Highly Selective RET Inhibitor, in Patients with RET Fusion+ Non-Small Cell Lung Cancer
16:20 - 16:30 | Presenter: Geoffrey R. Oxnard | Author(s): Vivek Subbiah, Keunchil Park, Todd M. Bauer, Lori J Wirth, Vamsidhar Velcheti, Manisha Shah, Benjamin Besse, Valentina Boni, Karen L. Reckamp, Herbert H Loong, Lyudmila Bazhenova, Ben J Solomon, Daniel S.W. Tan, Jyoti Patel, Melissa L. Johnson, Anas Gazzah, Tony S. Mok, Steve Smith, Brian Tuch, Kevin Ebata, Edward Y Zhu, Michele M Nguyen, Xin Huang, Scott Cruickshank, S Michael Rothenberg, Alexander Drilon
- Abstract
Loading...
-
+
P2.17 - Treatment of Locoregional Disease - NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.17-27 - IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC with Atezolizumab + Chemotherapy
16:45 - 18:00 | Presenter: Naiyer A Rizvi | Author(s): David R. Gandara, Ben J Solomon, Anthony W. Kim, Alessandro Brunelli, Shawn W. Sun, Barbara J Gitlitz, Kosei Tajima, Wei Lin, Alan Sandler, Solange Peters
- Abstract
Loading...